发明名称 |
Use of CD44v6 in the treatment of ophthalmic diseases |
摘要 |
<p>The present invention relates to the use of peptide compounds for the prevention and/or treatment of ophthalmic diseases.
In particular, the present invention relates to a peptide compound comprising an amino acid sequence displayed by amino acids 7 to 11 of SEQ ID NO: 2 (KEQWFGNRWHEGYR) or of SEQ ID NO: 1 (KEKWFENEWQGKNP), or a functionally active derivative thereof, or a pharmaceutically acceptable salt thereof, for use in the prevention and/or treatment of an ophthalmic disease in an individual. While SEQ ID NO: 2 is a part of the human CD44v6, SEQ ID NO: 1 is a part of the rat CD44v6.</p> |
申请公布号 |
EP2266593(A1) |
申请公布日期 |
2010.12.29 |
申请号 |
EP20090008272 |
申请日期 |
2009.06.24 |
申请人 |
KARLSRUHER INSTITUT FUER TECHNOLOGIE |
发明人 |
MATZKE, ALEXANDRA;PONTA, HELMUT;ORIAN-ROUSSEAU, VERONIQUE;TREMMEL, MARTINA |
分类号 |
A61K38/17;A61P27/00 |
主分类号 |
A61K38/17 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|